Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women

NCT02209623 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02209623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
Lead sponsor
Vanderbilt University
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
December 18, 2017
Enrollment
375 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pertussis